Position in ENTA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,376,807
-$1,124,707 QoQ
Shares Held
267,364
-6.3% QoQ
Ownership
0.919%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,513,200,662 across 316 Biotechnology names. ENTA ranks #125 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in ENTA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,376,807 | 267,364 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,501,514 | 285,448 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $726,842 | 60,722 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $593,119 | 78,455 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $429,952 | 77,890 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $369,627 | 64,283 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,981,422 | 191,257 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,393,704 | 184,557 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,492,615 | 257,309 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,126,303 | 332,232 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,367,693 | 211,969 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $633,932 | 29,623 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $1,493,943 | 32,114 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $736,139 | 14,192 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $642,446 | 13,591 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $6,182,959 | 82,682 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,680,038 | 64,778 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,890,444 | 65,677 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,176,701 | 64,410 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,746,561 | 65,239 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,149,554 | 46,954 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,351,417 | 66,748 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,283,609 | 102,734 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||